BofA reinstated coverage of CRH (CRH) with a Buy rating and $128 price target CRH reported negative organic volumes the last five quarters, but the firm sees an organic growth inflection ahead as it argues that end markets are lining up for such an inflection with non-residential construction starts picking up, interest rates easing and state infrastructure budgets pointing up next year.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRH: